Deelo vs Viz.ai: Disease Analysis Software Compared for 2026

Businesses looking for disease analysis software often narrow their search to Viz.ai — and for good reason. FDA-cleared AI for stroke, pulmonary embolism, and cardiac detection. But not every team is the ideal Viz.ai buyer. Deelo takes a fundamentally different approach: instead of selling a single-purpose tool, it bundles Disease Analysis with 50+ integrated business apps under one subscription.

Viz.ai is best known for its position in the Disease Analysis space. Strengths commonly cited by buyers include: FDA-cleared AI for stroke, pulmonary embolism, and cardiac detection; Real-time notification system that alerts specialists within minutes; Strong hospital adoption with proven clinical outcome improvements. The typical price range is Custom enterprise pricing (hospital contracts), and it is best suited for hospital emergency departments and stroke centers needing real-time ai triage. Trade-offs buyers often mention — your mileage may vary depending on your workflow — include: Narrow focus on acute care — limited chronic disease or screening use cases; No practice management, CRM, or business operations capabilities; Enterprise pricing model requires hospital-level contracts.

Deelo is an all-in-one business platform that provides Disease Analysis alongside CRM, invoicing, scheduling, field service, marketing, helpdesk, and dozens more apps — all connected through a unified data layer. Instead of patching together five or six SaaS subscriptions, teams run their entire operation from Deelo at a fraction of the combined cost.

Choose Viz.ai if hospital emergency departments and stroke centers needing real-time ai triage and you do not need tools outside Disease Analysis. Choose Deelo if you want CRM, invoicing, scheduling, and Disease Analysis in one place without paying for multiple subscriptions. Deelo is particularly strong for small and mid-size businesses that are tired of juggling disconnected tools and want one source of truth.

Both platforms are capable Disease Analysis tools, but they serve different needs. Viz.ai is a deep, focused Disease Analysis tool at Custom enterprise pricing (hospital contracts). Deelo is a full business platform starting at $19/seat/mo that includes Disease Analysis plus 50+ additional apps. If you are currently paying for Disease Analysis and separate tools for CRM, invoicing, and scheduling, switching to Deelo can simplify your stack and save money.